According to recent studies, SF3B1 mutation has been identified as a unique subtype of MDS that encompasses more than 90% of MDS cases with ineffective erythropoiesis, and at least 5% ring sideroblasts [147, 148]. The gene discussed is SF3B1; the disease is myelodysplastic syndrome.